Accession Number: | 0001415889-22-005828 |
Date: | 2022-05-26 |
Issuer: | SIGILON THERAPEUTICS, INC. (SGTX) |
Original Submission Date: |
PATEL KAVITA
C/O SIGILON THERAPEUTICS, INC.
100 BINNEY STREET STE 600
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.7632 | 2022-05-26 | deemed execution date | A | 8,888 (a) | 2032-05-25 | common stock 8,888 | $0.76 | 8,888 | direct |
ID | footnote |
---|---|
f1 | the option was issued pursuant to the sigilon therapeutics, inc. 2020 equity incentive plan. the option will vest as to 100% on may 26, 2023. |